Teva Pharmaceutical Industries Limited Working Capital to Net Assets Ratio
Teva Pharmaceutical Industries Limited working capital to net assets ratio. Teva Pharmaceutical Industries Limited (TEV) has a Working Capital to Net Assets ratio of 2.2% as of March 2026. Working capital of €178.00 Million (current assets of €13.71 Billion minus current liabilities of €13.53 Billion) is measured against net assets of €8.23 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check how tangible is Teva Pharmaceutical Industries Limited's equity to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Teva Pharmaceutical Industries Limited (2015–2025)
Working capital to net assets ratio of Teva Pharmaceutical Industries Limited from 2015 to 2025. This chart shows how Teva Pharmaceutical Industries Limited's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of March 2026, the ratio stands at 2.2%, reflecting working capital of €178.00 Million against net assets of €8.23 Billion EUR. See TEV defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Teva Pharmaceutical Industries Limited Working Capital to Net Assets Ratio by Year (2015–2025)
Teva Pharmaceutical Industries Limited working capital to net assets ratio by year from 2015 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Teva Pharmaceutical Industries Limited from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Teva Pharmaceutical Industries Limited assets under control.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 6.2% | €490.00 Million | €7.91 Billion | €13.95 Billion | €13.46 Billion | ▲ +10.5 pp |
| 2024 | -4.3% | €-244.00 Million | €5.72 Billion | €12.55 Billion | €12.80 Billion | ▼ -7.2 pp |
| 2023 | 2.9% | €238.00 Million | €8.13 Billion | €12.48 Billion | €12.25 Billion | ▼ -3.8 pp |
| 2022 | 6.7% | €582.00 Million | €8.69 Billion | €12.05 Billion | €11.47 Billion | ▼ -7.1 pp |
| 2021 | 13.7% | €1.55 Billion | €11.24 Billion | €12.57 Billion | €11.03 Billion | ▲ +15.2 pp |
| 2020 | -1.4% | €-159.00 Million | €11.06 Billion | €13.01 Billion | €13.16 Billion | ▼ 0.0 pp |
| 2019 | -1.4% | €-210.00 Million | €15.06 Billion | €13.46 Billion | €13.67 Billion | ▲ +1.9 pp |
| 2018 | -3.3% | €-528.00 Million | €15.79 Billion | €13.79 Billion | €14.32 Billion | ▲ +10.2 pp |
| 2017 | -13.5% | €-2.54 Billion | €18.75 Billion | €15.38 Billion | €17.92 Billion | ▼ -9.9 pp |
| 2016 | -3.6% | €-1.26 Billion | €34.99 Billion | €17.23 Billion | €18.49 Billion | ▼ -21.6 pp |
| 2015 | 18.0% | €5.39 Billion | €29.93 Billion | €18.40 Billion | €13.01 Billion | — |